Caffeine Inhibits NLRP3 Inflammasome Activation by Downregulating TLR4/MAPK/NF-κB Signaling Pathway in an Experimental NASH Model. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatohepatitis.